These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3726533)
21. Relationship of cytosolic ion fluxes and protein kinase C activation to platelet-derived growth factor induced competence and growth in BALB/c-3T3 cells. Zagari M; Stephens M; Earp HS; Herman B J Cell Physiol; 1989 Apr; 139(1):167-74. PubMed ID: 2708452 [TBL] [Abstract][Full Text] [Related]
22. Expression of platelet-derived growth factor-independent phenotypes in BALB/c 3T3 cell variant with high susceptibility to chemically or physically induced neoplastic cell transformation: dissociation from activation of protein kinase C. Tatsuka M; Owada MK; Mitsui H Cancer Res; 1992 Aug; 52(15):4232-41. PubMed ID: 1638537 [TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor (EGF) is required only during the traverse of early G1 in PDGF stimulated density-arrested BALB/c-3T3 cells. Leof EB; Van Wyk JJ; O'Keefe EJ; Pledger WJ Exp Cell Res; 1983 Aug; 147(1):202-8. PubMed ID: 6604639 [TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-1 (IGF-1), insulin, and epidermal growth factor (EGF) are survival factors for density-inhibited, quiescent Balb/c-3T3 murine fibroblasts. Tamm I; Kikuchi T J Cell Physiol; 1990 Jun; 143(3):494-500. PubMed ID: 2193035 [TBL] [Abstract][Full Text] [Related]
28. Cell cycle regulation of human diploid fibroblasts: possible mechanisms of platelet-derived growth factor. Larsson O; Latham C; Zickert P; Zetterberg A J Cell Physiol; 1989 Jun; 139(3):477-83. PubMed ID: 2738097 [TBL] [Abstract][Full Text] [Related]
29. The interaction with PDGF as a source of G1 phase heterogeneity in normal mouse fibroblasts. Toschi L; Zippel R; Martegani E; Sturani E Cell Biol Int Rep; 1986 Jul; 10(7):575-82. PubMed ID: 2425987 [TBL] [Abstract][Full Text] [Related]
34. Post-transcriptional control of protein synthesis in Balb/c-3T3 cells by platelet-derived growth factor and platelet-poor plasma. Cochran BH; Lillquist JS; Stiles CD J Cell Physiol; 1981 Dec; 109(3):429-38. PubMed ID: 6798044 [TBL] [Abstract][Full Text] [Related]
35. Identification of the cellular mechanisms responsible for platelet-derived growth factor induced alterations in cytoplasmic vinculin distribution. Herman B; Harrington MA; Olashaw NE; Pledger WJ J Cell Physiol; 1986 Jan; 126(1):115-25. PubMed ID: 3080438 [TBL] [Abstract][Full Text] [Related]
36. Characteristics of 30-, 63-, and 89-kilodalton proteins whose secretion from mouse fibroblasts is altered by beta-interferon. Tominaga S; Tominaga K; Lengyel P J Biol Chem; 1985 Dec; 260(30):16406-10. PubMed ID: 4066715 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide. Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796 [TBL] [Abstract][Full Text] [Related]
38. Regulation of glucose transport activity and expression of glucose transporter mRNA by serum, growth factors and phorbol ester in quiescent mouse fibroblasts. Kitagawa T; Tanaka M; Akamatsu Y Biochim Biophys Acta; 1989 Mar; 980(1):100-8. PubMed ID: 2923892 [TBL] [Abstract][Full Text] [Related]
40. An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis. Pledger WJ; Stiles CD; Antoniades HN; Scher CD Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2839-43. PubMed ID: 275855 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]